142 related articles for article (PubMed ID: 34592869)
41. Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity.
McLoone EM; O'Keefe M; McLoone SF; Lanigan BM
J AAPOS; 2006 Oct; 10(5):454-9. PubMed ID: 17070482
[TBL] [Abstract][Full Text] [Related]
42. Frequency and Outcome of Retinopathy of Prematurity at Tertiary Care Hospital in Pakistan.
Awan MA; Haq A; Shaheen F; Nazir S; Choudhry S
J Coll Physicians Surg Pak; 2022 Jul; 32(7):895-898. PubMed ID: 35795939
[TBL] [Abstract][Full Text] [Related]
43. Screening premature infants for retinopathy of prematurity in a tertiary hospital in Saudi Arabia.
Mgharbil E; Raffa LH; Alessa S; Alamri A
Ann Saudi Med; 2020; 40(2):87-93. PubMed ID: 32241163
[TBL] [Abstract][Full Text] [Related]
44. Structural sequelae and refractive outcome after successful laser treatment for threshold retinopathy of prematurity.
Dhawan A; Dogra M; Vinekar A; Gupta A; Dutta S
J Pediatr Ophthalmol Strabismus; 2008; 45(6):356-61. PubMed ID: 19043947
[TBL] [Abstract][Full Text] [Related]
45. Is being small for gestational age a risk factor for strabismus and refractive errors at 3 years of age?
Petriçli İS; Kara C; Arman A
Turk J Pediatr; 2020; 62(6):1049-1057. PubMed ID: 33372444
[TBL] [Abstract][Full Text] [Related]
46. Severe retinopathy of prematurity and visual outcomes in British Columbia: a 10-year analysis.
Schiariti V; Matsuba C; Houbé JS; Synnes AR
J Perinatol; 2008 Aug; 28(8):566-72. PubMed ID: 18368058
[TBL] [Abstract][Full Text] [Related]
47. [A study of refractive state in premature infants without retinopathy of prematurity and full-term children at the age of 0 to 6].
Tian M; Zhou L; Luo Q; Ye M; Xu Y
Zhonghua Yan Ke Za Zhi; 2015 Jul; 51(7):505-9. PubMed ID: 26310253
[TBL] [Abstract][Full Text] [Related]
48. Screening for retinopathy of prematurity in a tertiary hospital in Istanbul: incidence and risk factors.
Akçakaya AA; Yaylali SA; Erbil HH; Sadigov F; Aybar A; Aydin N; Akçay G; Acar H; Mesçi C; Yetik H
J Pediatr Ophthalmol Strabismus; 2012; 49(1):21-5. PubMed ID: 21323244
[TBL] [Abstract][Full Text] [Related]
49. Refractive Status in Nepalese Pre-Term and Full-Term Infants Early in Life.
Uprety S; Morjaria P; Shrestha JB; Shrestha GS; Khanal S
Optom Vis Sci; 2017 Oct; 94(10):957-964. PubMed ID: 28858003
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity.
Mori Y; Arima M; Ueda E; Fujiwara K; Seki E; Nakama T; Tsukamoto S; Akiyama M; Sonoda KH
Eye (Lond); 2021 Oct; 35(10):2820-2825. PubMed ID: 33257802
[TBL] [Abstract][Full Text] [Related]
51. Frequency and natural history of retinopathy of prematurity (ROP). A prospective study in a Swedish city 1986-1990.
Maly E
Acta Ophthalmol Suppl (1985); 1993; (210):52-5. PubMed ID: 8329955
[TBL] [Abstract][Full Text] [Related]
52. Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.
Xu Y; Zhou X; Zhang Q; Ji X; Zhang Q; Zhu J; Chen C; Zhao P
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8229-36. PubMed ID: 24204053
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
Gunay M; Sukgen EA; Celik G; Kocluk Y
Curr Eye Res; 2017 Mar; 42(3):462-469. PubMed ID: 27420302
[TBL] [Abstract][Full Text] [Related]
54. Ocular sequelae in extremely premature infants at 5 years of age.
Hebbandi SB; Bowen JR; Hipwell GC; Ma PJ; Leslie GI; Arnold JD
J Paediatr Child Health; 1997 Aug; 33(4):339-42. PubMed ID: 9323624
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of Refractive Errors and Ocular Biometric Outcomes after Intravitreal Bevacizumab for Retinopathy of Prematurity.
Gunay M; Sekeroglu MA; Bardak H; Celik G; Esenulku CM; Hekimoglu E; Bardak Y
Strabismus; 2016 Jun; 24(2):84-8. PubMed ID: 27120579
[TBL] [Abstract][Full Text] [Related]
56. Retinopathy of prematurity in southern Taiwan: a 10-year tertiary medical center study.
Li ML; Hsu SM; Chang YS; Shih MH; Lin YC; Lin CH; Tsai HJ; Tseng SH
J Formos Med Assoc; 2013 Aug; 112(8):445-53. PubMed ID: 24016609
[TBL] [Abstract][Full Text] [Related]
57. Refractive error at birth and its relation to gestational age.
Varughese S; Varghese RM; Gupta N; Ojha R; Sreenivas V; Puliyel JM
Curr Eye Res; 2005 Jun; 30(6):423-8. PubMed ID: 16020274
[TBL] [Abstract][Full Text] [Related]
58. Temporal Profile of Retinopathy of Prematurity in Extremely Premature Compared to Premature Infants.
Venincasa VD; Bugg V; Dvorak J; Ding K; Bhatti F; Siatkowski RM
J Pediatr Ophthalmol Strabismus; 2019 Mar; 56(2):116-123. PubMed ID: 30889266
[TBL] [Abstract][Full Text] [Related]
59. Effect of laser photocoagulation, antiangiogenic therapy or a combined treatment on refractive outcomes of newborns with ROP.
Del Portillo MC; Navarro PI; Duran D; Serrano JC
Eur J Ophthalmol; 2022 Nov; 32(6):3295-3302. PubMed ID: 35139693
[TBL] [Abstract][Full Text] [Related]
60. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB
Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
